Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 2 October, 2014 by The TZ Newswire Staff

Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

Ariad Pharmaceuticals stock is among today’s top gainers after the Food and Drug Administration divvies a prized designation one of Ariad’s pipeline products.

See also
- Next Article Is It Time to Buy American Airlines Group Inc. Stock?
- Previous Article Oil heads to bear market as Saudis signal price war
Editorial Calender

October 2014

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30 31

« Sep Nov »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 2 October, 2014 by The TZ Newswire Staff

Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

See also

Editorial Calender

Recent Tags